Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1326, 2002-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Eptifibatide cost-effective option for coronary interventions
Inpharma, Vol. 1, Iss. 1310, 2001-01 ,pp. :
Access to resources
Recommend
Eptifibatide `highly cost-effective' for coronary stenting
Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. :
Eptifibatide `highly cost-effective' for coronary stenting
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. :
GPIIb-IIIa antagonists cost effective in acute coronary syndromes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 499, 2006-01 ,pp. :